Stock HLTH CUE HEALTH INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Cue Health Inc.

Equities

HLTH

US2297901009

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
0.0676 USD -6.76% Intraday chart for Cue Health Inc. -26.92% -58.40%
May. 28 Cue Health Inc. Filed for Bankruptcy CI
May. 16 Cue Health Inc. Announces Board of Directors Resignations CI

Evolution of the average Target Price on Cue Health Inc.

Price target over the last 5 years

History of analyst recommendation changes

cf9170f71e5fb1b84cfaea2a.V9CSdcZn5mW-vAhyMiXz1tRIBX4i0vLqgqR7Y4QUGYA.ZajYA6MxrQDJ2j09BFOR540sUi9E4sG1xPMUFu5aevMTmOoFn1_eJIv3Yw~71b49f64c30beafbe265f74061f342fa

Analyst Recommendations on Cue Health Inc.

BTIG Downgrades Cue Health to Neutral From Buy MT
Goldman Sachs Trims Price Target on Cue Health to $0.50 From $0.75, Maintains Neutral Rating MT
Goldman Sachs Downgrades Cue Health to Neutral From Buy, Trims Price Target to $0.75 From $2.75 MT
BTIG Cuts Cue Health's Price Target to $3 From $5, Maintains Buy Rating MT
Goldman Sachs Adjusts Price Target on Cue Health to $3 From $3.50, Maintains Buy Rating MT
Cowen Trims Price Target on Cue Health to $7 From $9, Maintains Outperform Rating MT
Goldman Sachs Trims Cue Health's Price Target to $6 From $7, Maintains Buy Rating MT
Morgan Stanley Trims Cue Health's Price Target to $8 From $10, Keeps Equalweight Rating MT
Goldman Sachs Adjusts Price Target for Cue Health to $7 From $8.50, Maintains Buy Rating MT
Morgan Stanley Adjusts Cue Health's Price Target to $11 from $12, Keeps Equalweight Rating MT
CUE HEALTH : Morgan Stanley Starts Cue Health at Equalweight with $12 Price Target MT
CUE HEALTH : Goldman Sachs Initiates Cue Health at Buy Rating With $19 Price Target MT
CUE HEALTH : Cowen Starts Cue Health at Outperform With $14 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
0.0676 USD
Average target price
0.5 USD
Spread / Average Target
+639.64%
High Price Target
0.5 USD
Spread / Highest target
+639.64%
Low Price Target
0.5 USD
Spread / Lowest Target
+639.64%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Cue Health Inc.

BTIG
Goldman Sachs
Cowen
Morgan Stanley

Ratings for Cue Health Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. HLTH Stock
  4. Consensus Cue Health Inc.